rs41275106
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001845.6(COL4A1):c.85-69T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.164 in 1,525,936 control chromosomes in the GnomAD database, including 21,998 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.16 ( 2182 hom., cov: 33)
Exomes 𝑓: 0.16 ( 19816 hom. )
Consequence
COL4A1
NM_001845.6 intron
NM_001845.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0200
Publications
3 publications found
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
- brain small vessel disease 1 with or without ocular anomaliesInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
- autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
- microangiopathy and leukoencephalopathy, pontine, autosomal dominantInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- familial porencephalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pontine autosomal dominant microangiopathy with leukoencephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinal arterial tortuosityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 13-110242803-A-G is Benign according to our data. Variant chr13-110242803-A-G is described in ClinVar as Benign. ClinVar VariationId is 1242718.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.195 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.164 AC: 25007AN: 152120Hom.: 2183 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
25007
AN:
152120
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.164 AC: 225721AN: 1373698Hom.: 19816 AF XY: 0.166 AC XY: 114144AN XY: 688354 show subpopulations
GnomAD4 exome
AF:
AC:
225721
AN:
1373698
Hom.:
AF XY:
AC XY:
114144
AN XY:
688354
show subpopulations
African (AFR)
AF:
AC:
6362
AN:
31520
American (AMR)
AF:
AC:
3094
AN:
44598
Ashkenazi Jewish (ASJ)
AF:
AC:
3416
AN:
25638
East Asian (EAS)
AF:
AC:
211
AN:
39382
South Asian (SAS)
AF:
AC:
15571
AN:
84546
European-Finnish (FIN)
AF:
AC:
6869
AN:
51328
Middle Eastern (MID)
AF:
AC:
1012
AN:
5624
European-Non Finnish (NFE)
AF:
AC:
179918
AN:
1033684
Other (OTH)
AF:
AC:
9268
AN:
57378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
8261
16523
24784
33046
41307
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
6010
12020
18030
24040
30050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.164 AC: 25029AN: 152238Hom.: 2182 Cov.: 33 AF XY: 0.160 AC XY: 11889AN XY: 74422 show subpopulations
GnomAD4 genome
AF:
AC:
25029
AN:
152238
Hom.:
Cov.:
33
AF XY:
AC XY:
11889
AN XY:
74422
show subpopulations
African (AFR)
AF:
AC:
8245
AN:
41532
American (AMR)
AF:
AC:
1551
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
454
AN:
3468
East Asian (EAS)
AF:
AC:
41
AN:
5196
South Asian (SAS)
AF:
AC:
831
AN:
4826
European-Finnish (FIN)
AF:
AC:
1283
AN:
10600
Middle Eastern (MID)
AF:
AC:
52
AN:
294
European-Non Finnish (NFE)
AF:
AC:
12038
AN:
68014
Other (OTH)
AF:
AC:
320
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1081
2162
3243
4324
5405
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
276
552
828
1104
1380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
327
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.